Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
Titel:
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial
Auteur:
Li, Jing-Xin Hou, Li-Hua Meng, Fan-Yue Wu, Shi-Po Hu, Yue-Mei Liang, Qi Chu, Kai Zhang, Zhe Xu, Jun-Jie Tang, Rong Wang, Wen-Juan Liu, Pei Hu, Jia-Lei Luo, Li Jiang, Rong Zhu, Feng-Cai Chen, Wei
Verschenen in:
The Lancet global health
Paginering:
Jaargang 5 (2017) nr. 3 pagina's e324-e334
Jaar:
2017
Inhoud:
Uitgever:
The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND license